DOP15 Results of a Pragmatic Multicentred Randomised Controlled Trial Investigating the Use of Personalised Golimumab Dosing in Ulcerative Colitis: the GOAL-ARC Study (GLM Dose Optimisation to Adequate Levels to Achieve Response in Colitis)
JOURNAL OF CROHNS & COLITIS（2024）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined